Dr. Sherbenou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
University of Colorado Blood Disorders Center
1665 Aurora Ct
Aurora, CO 80045Phone+1 720-848-6400- Is this information wrong?
Summary
- I am a physician scientist at the University of Colorado Anschutz Medical Campus focused on patient care and translational research for multiple myeloma.
Clinical Expertise
- Hematologic oncology, Laboratory research, Plasma cell disorders, Autologous stem cell transplantation, Translational Research, POEMS syndrome, Monoclonal gammopathy of unknown significance, Waldenstrom's macroglobulinemia
Education & Training
- University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2012 - 2014
- University of Utah HealthResidency, Internal Medicine, 2009 - 2012
- Oregon Health and Science University School of MedicineClass of 2009
Certifications & Licensure
- CA State Medical License 2012 - Present
- CO State Medical License 2015 - 2025
- UT State Medical License 2010 - 2014
Awards, Honors, & Recognition
- Translational Research Training in Hematology European Hematology Association/American Society of Hematology, 2018
- Loan Repayment Program National Cancer Institute
- 2016 Young Investigator Award National Comprehensive Cancer Network (NCCN) Foundation
- Join now to see all
Publications & Presentations
PubMed
- MYC Inhibition Potentiates CD8+ T Cells Against Multiple Myeloma and Overcomes Immunomodulatory Drug Resistance.Lorraine N Davis, Zachary J Walker, Lauren T Reiman, Sarah E Parzych, Brett M Stevens, Craig T Jordan, Peter A Forsberg, Daniel W Sherbenou> ;Clinical Cancer Research. 2024 May 9
- Ex Vivo Efficacy of SAR442257 Anti-CD38 Trispecific T-cell Engager in Multiple Myeloma Relapsed After Daratumumab and BCMA-targeted Therapies.Alana L Keller, Lauren T Reiman, Olivia Perez de Acha, Sarah E Parzych, Peter A Forsberg, Peter S Kim, Kamlesh Bisht, Hongfang Wang, Helgi van de Velde, Daniel W Sherb...> ;Cancer Research Communications. 2024 Mar 12
- Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.Shaji K Kumar, Natalie S Callander, Kehinde Adekola, Larry D Anderson Jr, Muhamed Baljevic, Rachid Baz, Erica Campagnaro, Jorge J Castillo, Caitlin Costello, Christoph...> ;Journal of the National Comprehensive Cancer Network. 2024 Jan 1
- Join now to see all
Press Mentions
- American Cancer Society Awards 90 New Research and Career Development Grants Totaling $45 MillionApril 13th, 2023
- First Person – Shelby BearrowsJuly 1st, 2019
- NCCN Foundation Awards Grants to Five Young InvestigatorsApril 1st, 2016
- Join now to see all
Grant Support
- Targeting Cancer Initiating Cells in Multiple MyelomaNational Cancer Institute/National Institutes of Health2018–2023
- A patient-derived xenograft model of multiple myeloma to test anti-CD46 antibody drug conjugate for curative potential.National Comprehensive Cancer Network (NCCN Foundation2016–2018
Committees
- Committee Member, Protocol Review Committee, University of Colorado Cancer Center 2016 - Present
- Interviewer/Committee Member, Hematology/Oncology Fellowship Admissions 2016 - Present
- Co-chair, Cancer Biology Graduate Program Seminar Series 2016 - Present
- Faculty Mentor, Cancer Biology Graduate Program Retreat Organizing Committee 2016 - Present
Research History
- Ex Vivo Drug Sensitivity Screening to Personalize Treatment for Multiple Myeloma2016 - Present
- Targeting Multiple Myeloma with the CD46-Antibody Drug Conjugate2013 - Present
- Screening for Drug Resistance Mutations in Patients with Chronic Myeloid Leukemia on Treatment with Imatinib/Gleevec2003 - 2007
- Characterization of Sodium Channel Isoform Expression in the Peripheral Nervous System1995 - 1997
- Two-Hybrid Screen for SUR2 Interaction Partners in the C.elegans Ras Pathway1994 - 1995
Professional Memberships
- Member
- Member
- Society for Immunotherapy of CancerMember
- International Myeloma SocietyMember
Hospital Affiliations
- University of Colorado HospitalAurora, Colorado
External Links
- Faculty Profilehttps://www.cudoctors.com/Find_A_Doctor/Profile/16907
- Lab Homepagehttp://sherbenoulab.org
- Linked-Inhttps://www.linkedin.com/in/daniel-sherbenou-45109983/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: